Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01G
- Chemical subgroupJ01GB
- Chemical substanceJ01GB05Neomycin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 318 registrations
- LomicinaLaboratórios Osório de Moraes Ltda
- NemicinaCellera Farmaceutica S.A.
- NeomiconCifarma Científica Farmacêutica Ltda
- PomicinaBelfar Ltda
Canada
Health Canada · 161 registrations
- Maxitrol0.1 % / W/V + 3.5 MG / ML + 6000 UNIT / ML · Suspension · Novartis Pharmaceuticals Canada INC
- Maxitrol0.1 % / W/W + 3.5 MG / G + 6000 UNIT / G · Ointment · Novartis Pharmaceuticals Canada INC
- Teva-Triacomb0.25 MG / G + 2.5 MG / G + 100000 UNIT / G + 1 MG / G · Cream · Teva Canada Limited
- Theraderm Cream
At a glance
- ATC code
- J01GB05
- ATC group
- Anti-infectives for systemic use
- Registers
- 9
- Historical lists
- 2
- Registrations
- 673
- With their own page
- 232
- Companies
- 257
All medicines with Neomycin
Human medicines from every register that match Neomycin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
567 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Neomycin Sulfate | United States | 500MG | tablet | Marketed | Bristol Myers Squibb |
| Neomycin and Polymyxin B SulfateCombination | United States | 40MG BASE/ML; 200,000 UNITS/ML | solution | Marketed | Watson Labs |
| Neomycin and Polymyxin B Sulfates and GramicidinCombination | United States | 0.025MG/ML; 1.75MG BASE/ML; 10,000 UNITS/ML | solution/drops | Marketed | Watson Labs |
| Neomycin and Polymyxin B Sulfates and DexamethasoneCombination | United States | 0.1%; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Neomycin and Polymyxin B Sulfates and HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Marketed | Sandoz |
| Neomycin and Polymyxin B Sulfates and HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | solution/drops | Marketed | Amneal |
| Neomycin and Polymyxin B Sulfates and HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Marketed | Sciegen Pharms |
| Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and HydrocortisoneCombination | United States | 400 UNITS/GM; 1%; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Neomycin and Polymyxin B Sulfates and Bacitracin ZincCombination | United States | 400 UNITS/GM; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Neomycin Sulfate-Triamcinolone AcetonideCombination | United States | 3.5MG BASE/GM; 0.1% | ointment | Not marketed | Fougera |
| Neomycin Sulfate-Triamcinolone AcetonideCombination | United States | 3.5MG BASE/GM; 0.1% | cream | Not marketed | Pharmaderm |
| Neomycin Sulfate and Polymyxin B Sulfate GramicidinCombination | United States | 0.025MG/ML; 1.75MG BASE/ML; 10,000 UNITS/ML | solution/drops | Not marketed | Pharmafair |
| Neomycin Sulfate, Polymyxin B Sulfate & HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Not marketed | Pharmafair |
| Neomycin Sulfate-Polymyxin B Sulfate-HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Not marketed | Pharmafair |
| Neomycin Sulfate-Polymyxin B Sulfate-HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | solution/drops | Not marketed | Pharmafair |
| Neomycin Sulfate-Dexamethasone Sodium PhosphateCombination | United States | 0.1% PHOSPHATE; 3.5MG BASE/ML | solution/drops | Not marketed | Alcon Pharms LTD |
| Neomycin and Polymyxin B Sulfates and DexamethasoneCombination | United States | 0.1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Not marketed | Alcon Pharms LTD |
| Neomycin Sulfate and Dexamethasone Sodium PhosphateCombination | United States | 0.1% PHOSPHATE; 3.5MG BASE/ML | solution/drops | Not marketed | Bausch and Lomb |
| Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & HydrocortisoneCombination | United States | 400 UNITS/GM; 1%; 3.5MG BASE/GM; 5,000 UNITS/GM | ointment | Not marketed | Pharmafair |
| Neomycin Nasal Spray | Saudi Arabia | Authorised | Laboratories Aventis (Usipher) | ||
| Neomycin-Hydrocortisoine OintCombination | Saudi Arabia | Authorised | Laboratories Aventis (Usipher) | ||
| Bacitracin-Neomycin-PolymyxinCombination | United States | 400 UNITS/GM; 3.5MG BASE/GM; 5,000 UNITS/GM | ointment | Not marketed | Pharmaderm |
| Dexamethason-neomycin GalenikaCombination | Serbia | 1mg/mL+3.5mg/mL | kapi za uši/oči, rastvor | Authorised | Galenika Ad Beograd |
| Neosporin G.U. IrrigantCombination | United States | 40MG BASE/ML; 200,000 UNITS/ML, 800MG BASE/20ML; 4,000,000 UNITS/20ML (EQ 40MG BASE/ML | solution | Marketed | Monarch Pharms |
| NeosporinCombination | United States | 3.5MG BASE/GM; 10,000 UNITS/GM | cream | Not marketed | Glaxosmithkline |